Table 15Interaction Effects for Claims-based Secondary Outcome Measures

OutcomesICC: clinics, participantsTreatment × time interactionLeast-squares estimates (95% CI)No. of participants: PS, SD
F value (df)P valuePSSD
Medication adherence: MPR for antipsychotics 0.000, 0.5251.84 (4, 992).1183----
 mo 0----0.76 (0.64-0.88)0.73 (0.59-0.86)198, 147
 mo 6----0.76 (0.63-0.88)0.72 (0.58-0.85)195, 151
 mo 12----0.75 (0.65-0.86)0.75 (0.62-0.88)181, 126
 mo 18----0.70 (0.54-0.85)0.72 (0.58-0.86)156, 98
 mo 24----0.75 (0.62-0.87)0.75 (0.60-0.91)147, 73
Medication adherence: MPR for antidepressants 0.003, 0.5771.63 (4, 1250).1653----
 mo 0----0.81 (0.75-0.87)0.76 (0.67-0.85)231, 188
 mo 6----0.82 (0.75-0.88)0.74 (0.64-0.84)225, 176
 mo 12----0.82 (0.75-0.89)0.80 (0.71-0.89)221, 158
 mo 18----0.79 (0.68-0.90)0.78 (0.68-0.87)202, 149
 mo 24----0.81 (0.74-0.87)0.79 (0.70-0.87)189, 102
Medication adherence: MPR for hypertension 0.000, 0.4852.14 (4, 652).0745----
 mo 0----0.67 (0.55-0.79)0.64 (0.49-0.78)118, 92
 mo 6----0.70 (0.58-0.83)0.65 (0.52-0.79)126, 98
 mo 12----0.74 (0.60-0.87)0.67 (0.54-0.81)125, 96
 mo 18----0.72 (0.60-0.84)0.73 (0.58-0.88)114, 86
 mo 24----0.71 (0.61-0.81)0.71 (0.56-0.85)102, 60
Medication adherence: MPR for diabetes med 0.000, 0.6265.89 (4, 293).0001a----
 mo 0----0.84 (0.72-0.95)0.78 (0.62-0.94)58, 40
 mo 6----0.85 (0.72-0.98)0.83 (0.67-0.99)52, 41
 mo 12----0.89 (0.76-1.01)0.82 (0.68-0.96)55, 47
 mo 18----0.86 (0.73-1.00)0.85 (0.71-1.00)51, 35
 mo 24----0.86 (0.74-0.97)0.79 (0.66-0.92)48, 29
Emergent care: composite of counts: BH_IP/ER, PH_IP/ER 0.001, 0.6449.91 (2, 2142)<.0001a^----
----
 mo 02.77 (2.00-3.54)3.58 (2.79-4.36)648, 449
 mo 12----2.83 (1.95-3.71)2.92 (2.11-3.74)620, 440
 mo 24----2.49 (1.70-3.27)2.72 (1.90-3.54)582, 310
Laboratory monitoring: total laboratory services in 12 mo 0.024, 0.5855.79 (2, 2142).0031a----
 mo 0----1.43 (1.01-1.85)1.19 (0.78-1.60)648, 449
 mo 12----1.52 (1.19-1.85)1.04 (0.69-1.39)620, 440
 mo 24----1.34 (1.11-1.57)1.25 (0.86-1.64)582, 310
Laboratory monitoring: EKG services in 12 mo 0.000, 0.1870.76 (2, 2142).4671----
 mo 0----0.14 (0.08-0.20)0.10 (0.02-0.18)648, 449
 mo 12----0.13 (0.08-0.18)0.12 (0.04-0.21)620, 440
 mo 24----0.13 (0.01-0.25)0.10 (0.02-0.19)582, 310
Laboratory monitoring: lipid labs services in 12 mo 0.026, 0.4401.30 (2, 2142).2741----
 mo 0----0.37 (0.07-0.67)0.25 (0.07-0.43)648, 449
 mo 12----0.44 (0.17-0.72)0.27 (0.06-0.49)620, 440
 mo 24----0.44 (0.16-0.72)0.36 (0.18-0.55)582, 310
Laboratory monitoring: glucose labs services in 12 mo 0.021, 0.6096.98 (2, 2142).0010a----
 mo 0----1.26 (0.84-1.68)1.08 (0.69-1.47)648, 449
 mo 12----1.36 (1.02-1.70)0.90 (0.61-1.19)620, 440
 mo 24----1.17 (0.88-1.46)1.12 (0.74-1.50)582, 310

Abbreviations: BH, behavioral health; ICC, integrated comprehensive care; EKG, electrocardiogram; ER, emergency room; IP, inpatient; MPR, medication possession ratio; PH, physical health; PS, provider-supported intervention arm; SD, self-directed intervention arm.

aSignificant at P < .05.

^Cohen's Effect Size f-square <0.02

From: Using Wellness Coaches and Extra Support to Improve the Health and Wellness of Adults with Serious Mental Illness

Cover of Using Wellness Coaches and Extra Support to Improve the Health and Wellness of Adults with Serious Mental Illness
Using Wellness Coaches and Extra Support to Improve the Health and Wellness of Adults with Serious Mental Illness [Internet].
Schuster J, Reynolds C III, Carney T, et al.
Copyright © 2019. UPMC Center for High-Value Health Care. All Rights Reserved.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License which permits noncommercial use and distribution provided the original author(s) and source are credited. (See https://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.